In the early part of the pandemic, many people charted the emerging picture of high Covid-19 death rates in developed countries with a large pharmaceutical industry presence (whose governments generally opposed HCQ) and low rates in poorer countries (that already used HCQ or were quick to adopt it). This resulted in a number of comparative analyses. Summary (i) An analysis by the group Americas Frontline Doctors by country, showed that access to HCQ was strongly linked to lower Covid-19 mortality. (ii) A worldwide country comparison generated automatically by the website…
Read More